SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

Share Price is delayed by 15 minutes
Get Live Data
140.00    0.50 (0.36%)
Bid:
138.00
Ask:
142.00
Spread: 4.00 (2.899%)
Market Cap: £79.15m
MVI Live PriceLast checked at - London Stock Exchange

Intraday Marwyn Val. Share Chart

Share Transfer

20 Apr 2022 17:52

RNS Number : 8124I
Marwyn Value Investors Limited
20 April 2022
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

 

LEI: 213800L5751QTTVEA774

20 April 2022

 

Marwyn Value Investors Limited (the "Company")

Share Transfer

 

The Company today announces that it was notified that on 20 April 2022, 4,460,555 of the Company's ordinary shares ("Ordinary Shares") which were held by Marwyn Long Term Incentive LP ("MLTI") and indirectly attributable to Mark Brangstrup Watts, have been transferred to Mark's personal account. There is no change in the ultimate beneficial ownership of these Ordinary Shares.

 

Following this transfer, MLTI holds 4,777,926 Ordinary Shares, representing approximately 8.41% of the Company's total voting rights and Mark Brangstrup Watts holds 4,483,282 Ordinary Shares, representing approximately 7.90% of the Company's total voting rights.

 

Mark Brangstrup Watts is a partner of Marwyn Investment Management LLP, the manager of the Company. Whilst Mark Brangstrup Watts is not a Person Discharging Managerial Responsibility ("PDMR") within the meaning of the UK version of Regulation (EU) 596/2014, as incorporated in the UK by virtue of the European Union (Withdrawal) Act 2018, as amended in relation to the Company, he has voluntarily disclosed the information above to the Company, and the Company is voluntarily disclosing the information above to the market, as if he were a PDMR in relation to the Company.

 

 

Company enquiries:

 

Company Secretary - Aztec Financial Services (Jersey) Limited

Chris Copperwaite / Magdala Mullegadoo

Telephone: 01534 833000

 

Investor Relations

Kam Bansil

Telephone: 020 7039 1901

 

Corporate Broker - Liberum Capital Limited

Chris Clarke / Owen Matthews

Telephone: 0203 100 2200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFERSLIIFIF
Date   Source Headline
26th Jun 20207:00 amRNSTransaction in Own Shares
25th Jun 20204:35 pmRNSNet Asset Value
25th Jun 20204:33 pmRNSNet Asset Value
22nd Jun 20207:00 amRNSTransaction in Own Shares
19th Jun 202010:55 amRNSNet Asset Value
19th Jun 202010:53 amRNSNet Asset Value
11th Jun 20205:48 pmRNSNet Asset Value
11th Jun 20205:46 pmRNSNet Asset Value
29th May 20208:00 amRNSDirector/PDMR Shareholding
28th May 20204:32 pmRNSNet Asset Value
28th May 20204:28 pmRNSNet Asset Value
28th May 20207:00 amRNSTransaction in Own Shares
27th May 202011:59 amRNSCompletion of Amended Accelerated Bookbuild
27th May 20207:00 amRNSAmended Accelerated Bookbuild
22nd May 20207:08 amRNSAccelerated Bookbuild
21st May 20205:27 pmRNSNet Asset Value
21st May 20205:25 pmRNSNet Asset Value
14th May 20206:03 pmRNSNet Asset Value
14th May 20205:59 pmRNSNet Asset Value
1st May 202011:51 amRNSNet Asset Value
1st May 202011:48 amRNSNet Asset Value
30th Apr 20204:48 pmRNSAudited Financial Statements December 2019
24th Apr 20208:59 amRNSNet Asset Value
24th Apr 20208:58 amRNSNet Asset Value
24th Apr 20207:00 amRNSTransaction in Own Shares
21st Apr 20207:00 amRNSTransaction in Own Shares
15th Apr 20205:42 pmRNSNet Asset Value
15th Apr 20205:41 pmRNSNet Asset Value
8th Apr 20207:00 amRNSTransaction in Own Shares
7th Apr 20207:00 amRNSTransaction in Own Shares
6th Apr 20207:00 amRNSTransaction in Own Shares
3rd Apr 202010:27 amRNSNet Asset Value
3rd Apr 202010:21 amRNSNet Asset Value
3rd Apr 20207:00 amRNSTransaction in Own Shares
26th Mar 20202:50 pmRNSNet Asset Value
26th Mar 20202:46 pmRNSNet Asset Value
24th Mar 20204:34 pmRNSExchange Procedure
20th Mar 20203:24 pmRNSNet Asset Value
20th Mar 20202:45 pmRNSNet Asset Value
13th Mar 202010:52 amRNSNet Asset Value
13th Mar 202010:48 amRNSNet Asset Value
9th Mar 20205:33 pmRNSNotification of major interests in shares
6th Mar 202012:40 pmRNSNet Asset Value
6th Mar 202012:37 pmRNSNet Asset Value
28th Feb 202010:47 amRNSNet Asset Value
28th Feb 202010:43 amRNSNet Asset Value
20th Feb 20204:33 pmRNSNet Asset Value
20th Feb 20204:32 pmRNSNet Asset Value
19th Feb 20207:00 amRNSTransaction in Own Shares
14th Feb 202012:19 pmRNSNet Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.